SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Izzy who wrote (5836)1/4/1999 3:02:00 AM
From: FNS   of 6136
 
Issy: Re <<look at the posts on Yahoo DD/MTC BBs. Several seem to think that DD will buyout MTC (apparently a long-standing rumor but appears to be more imminent now).>>

Can't comment intelligently on the rumors. Looks like DD is super buy if you can buy it near where it closed on Thursday...little risk with upside potential. MTC bothers me by selling off from the high of 50 ( near resistance level)...should move higher on the good news but perhaps the stock has discounted this somewhat. Note that PFE is also a co-promoter of celebrex.

You may have already seen:

12/31 14:05 *MONSANTO [MTC-news] SAYS GETS LETTER OF
APPROVAL FROM FDA FOR
CELEBREX

CHICAGO, Dec 31 (Reuters) - Life sciences firm Monsanto Co.
[MTC-news] said on Thursday the U.S. Food and Drug
Administration approved its Celebrex drug to treat rheumatoid
arthritis and osteoarthritis, which affect about 16 million
Americans. Celebrex is the first in a new class of drugs known as
COX-2 inhibitors. They are designed to work as well as other
analgesics such as aspirin, ibuprofen and naproxen, but without
potentially fatal side effects.

Analysts have said the market for Celebrex is huge, with potential
sales of $1 billion in the first year in the United States alone.
.....................

(However, I recall reading that if you're allergic to aspirin you shouldn't take celebrex!)

Am still long AGPH and am planning to add on a pull back to mid 50's.

(Off topic: Take a look at CNTO and CHIR if the bio's interest you.)

FNS
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News